[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
March 1974

Growth Hormone Secretion in Pituitary Disease

Author Affiliations

Loma Linda, Calif

From the Department of Medicine, Loma Linda University School of Medicine, Loma Linda, Calif, and the Department of Medicine, San Bernardino County General Hsopital, San Bernardino, Calif.

Arch Intern Med. 1974;133(3):459-463. doi:10.1001/archinte.1974.00320150133018

Human growth hormone (HGH) secretion was assessed in 47 consecutive patients with pituitary disease and was compared to the secretion of other pituitary hormones. Nine patients had acromegaly and HGH hypersecretion, two had adrenocorticotropic hormone hypersecretion and Cushing syndrome, and two had nonpuerperal galactorrhea (prolactin hypersecretion). Twenty-nine patients had HGH deficiency, 21 had follicle-stimulating hormone—luteinizing hormone deficiency, 15 had thyroid-stimulating hormone deficiency, and 10 had adrenocorticotropic hormone deficiency. Abnormal HGH secretion appears to be the most frequent endocrine dysfunction among patients with pituitary disease.